Germany
CABB is a leading contract development and manufacturing company (CDMO) for starting materials, active ingredients, and advanced intermediates. Specializing in the production of customized, highly complex molecules for leading companies, particularly in crop sciences, life sciences, and performance materials industry, CABB is positioned as "Your Partner in Fine Chemistry."
Founded in 2003 and headquartered in Germany, CABB boasts approximately 1,100 employees and operates six production sites in Europe, Asia, and the US, generating annual sales of about half a billion euros.
While no specific information is available regarding the last investment or the investors involved, CABB has demonstrated its potential as a key player in the manufacturing industry, offering promising opportunities for venture capitalists seeking to invest in the chemical manufacturing sector. With its strong market presence and strategic focus, CABB presents an appealing investment prospect within the manufacturing landscape.
